Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 46
- 试验地点
- 2
- 主要终点
- Knowledge of precision medicine for cancer care from time of enrollment to 1 month post-enrollment
研究概览
简要总结
The goal of this study is to learn if using a lay VA volunteer, who will assist patients with education regarding precision medicine, can improve care quality and outcomes for Veteran patients with lung cancer.
详细描述
Participants in the intervention group will receive 1:1 communication with a lay VA volunteer in addition to their usual clinical care. The lay VA volunteer will provide patients with education about precision medicine and support in their care. Researchers will compare a control group who will receive their usual oncology care as provided by clinical teams at the VA. There will be no change in their care.
All participants will be asked to complete a survey at the time of enrollment in the study, and also at 1 month. This survey will measure patient participation in their cancer care, satisfaction with healthcare decisions, and overall questions about knowledge of precision medicine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients 18 years old that have been newly diagnosed with any stage of lung cancer.
- •Patients must have the ability to understand and willingness to provide verbal consent.
- •Participants must speak English.
排除标准
- •Inability to consent to the study, severe mental illness (e.g. schizophrenia) or institutionalization.
- •Patients who anticipate moving care outside the Veterans Affairs Palo Alto Health Care System within 6 months.
结局指标
主要结局
Knowledge of precision medicine for cancer care from time of enrollment to 1 month post-enrollment
时间窗: Baseline
Using 8 multiple choice items adapted from an 8-item survey tool, Knowledge and Purpose of Molecular Profiling, by Davies et. al., 2020, we will assess knowledge of precision medicine for cancer care at time of enrollment and again at 1-month post-enrollment. For example one question asks 'tumor testing is helpful for guiding the treatment of lung cancer,' with answer choices: yes or no. Answers will be scored as number or percent correct.
次要结局
- Patient activation using the "Patient Activation Measure" survey(1 month post-enrollment)
- Receipt of molecular testing(6 months post-enrollment)
- Patient Satisfaction With Shared Decision Making using the "Shared Decision Making Questionnaire" Survey(1 month post-enrollment)
- Receipt of targeted therapy for those with an eligible molecular target(6 months post-enrollment)
研究者
Manali Indravadan Patel
Assistant Professor of Medicine
Stanford University